Astronova, Inc. (NASDAQ:ALOT)

AstroNova (NASDAQ:ALOT) ($13.65; MC $92.1m), a global leader in data visualization technologies has entered our radar due to strong Q3 2018 results and a recent asset purchase agreement with Honeywell.  On November 22, 2017 ALOT reported Q3 2018results:

• Sales of $28.8 million vs $23.3 million in the prior year

• EPS of $0.21 vs $0.15 in the prior year

• Backlog of $31.2 million vs $22.6 million in the prior year

Quotes from management:

“Healthy demand from both our Product Identification and Test and Measurement segments drove record revenue for AstroNova in the third quarter,” said AstroNova President and CEO Greg Woods. “Product Identification revenue was up 21.1 percent to $20.5 million for the quarter on double-digit inkjet printer unit growth and continued momentum for our related supplies and services. During the quarter, the QuickLabel® and TrojanLabel™ business units launched four new products that extended our breadth of leadership in the tabletop and label press printer market.

Looking ahead, we are focused on driving organic growth through product innovation and geographic expansion, complemented by strategic acquisitions that advance our Product Identification and Test & Measurement growth objectives,” Woods concluded. “We are well positioned as we conclude fiscal 2018.”

On October 4, 2017, ALOT signed an exclusive worldwide asset purchase and licensing agreement with Honeywell International’s aerospace division. Under the agreement, AstroNova’s aerospace business unit will take over the manufacturing of new printers as well as support services and supplies for printers primarily used on two of the world’s most popular commercial aircraft brands: Boeing 737 and Airbus A320.

Q3 2013 Comments

"We will continue to drive AMI`s strategy of global growth, expanded distribution, and productivity improvement in the final quarter of fiscal 2015 and beyond. However, given the uncertainty evident in certain European markets, coupled with the upcoming final stage of our Oracle ERP conversion, we are facing some additional headwinds in our fourth quarter," Woods said. "Notwithstanding these issues, both of our segments are increasing their competitive positions in the market. In the QLS segment, our new pigment ink-based and narrow-format technologies continue to raise the bar for quality, performance and cost efficiency. Within the T&M segment, demand for our ruggedized aerospace printers is strong in both the airline-direct and OEM markets, and our established data acquisition technology continues on a growth path."

WEST WARWICK, RI--(Marketwire - Aug 23, 2011) - Astro-Med, Inc. (NASDAQ: ALOT) reports Net Income of $1,046,000, equal to 14 cents per diluted share, on record sales of $20,336,000 for the Second Quarter ended July 30, 2011.

The Company reported Net Income of $323,000, equal to 4 cents per diluted share, on sales of $17,753,000 for the comparable period of the prior year. Favorable foreign exchange currency rates increased this year's Second Quarter sales by approximately $450,000, or 2.5%, when compared to the previous year. Net Income in the Second Quarter includes income of $300,000 equal to 4 cents per diluted share related to the disposition on an insurance policy.

For the six months ended July 30, 2011, Astro-Med reported Net Income of $1,477,000, equal to 20 cents per diluted share, on sales of $39,196,000. During the comparable six-month period of the prior year, Net Income was $753,000, equal to 10 cents per diluted share, on sales of $34,830,000.

"Notwithstanding the current uncertainty in the global economies, we are cautiously optimistic that Astro-Med will continue its growth and profitability path during the second half of FY 2012. Hence, we are affirming guidance for the full year to have annual sales be $78.0 million to $79.5 million and earnings per share to be 35 cents to 38 cents per diluted share." Earnings Per Share forecast excludes the one time benefit of 4 cents per diluted share related to the life insurance proceeds recognized in the Second Quarter.

Astro-Med, Inc. Directors Declare Regular Cash Dividend

On August 22, 2011, the Directors of Astro-Med, Inc. declared the regular quarterly cash dividend of $0.07 per share, payable on October 3, 2011 to shareholders of record as of September 16, 2011.